The Joint Corp. · NASDAQ:JYNT

The Joint — JOINT — Q3 2022 Earnings Presentation

16 slides from The Joint's earnings presentation, Nov 3, 2022

  1. Slide 1: Q3 2022 Financial Results

    Q3 2022 Financial Results As of September 30 , 2022 | Reported on November 3, 2022

  2. Slide 2: Safe Harbor Statements

    Safe Harbor Statements Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and

  3. Slide 3: Forging the Chiropractic Dream

    The Joint © 2022 The Joint Corp. All Rights Reserved. 3 Forging the Chiropractic Dream Accelerating the Pace of Clinic Growth Harnessing the Power of Our Data

  4. Slide 4: Performance Overcomes Macroeconomic Pressures

    Performance Overcomes Macroeconomic Pressures 4 Q3 2022 Q3 2021 Revenue $26.6M $21.0M Operating Income $500k $1.3M Net Income $491k $1.9M Adjusted EBITDA 2 $3.1M $3.3M Unrestricted cash $10.3M at Sept. 30, 2022, compared to $19.5 M at December 31, 2021, reflecting continued investment strategy © 202

  5. Slide 5: Opened 38 Clinics in Q3 2022

    12 26 82 175 242 265 309 352 394 453 515 610 690 4 47 61 47 48 60 64 96 115 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Sept. 30, 2022 TOTAL CLINICS OPEN Franchise Company Owned/Managed Opened 38 Clinics in Q3 2022, Up from 33 in Q3 2021 © 2022 The Joint Corp. All Rights Reserved. 5

  6. Slide 6: Pipeline for Clinic Openings Remains Strong

    62% sold by RDs in Q3 2022 69% of clinics supported by 19 RDs as of Sept. 30, 2022 RDs cover 55% of Metropolitan Statistical Areas (MSAs) as of Sept. 30, 2022 37 99 126 121 156 58 Dec. 31, 2017 Dec. 31, 2018 Dec. 31, 2019 Dec. 31, 2020 Dec. 31, 2021 Sept. 30, 2022 616 715 841 962 1118 1176 Dec. 31,

  7. Slide 7: Marketing Co-ops: Official Chiropractor for Athletic Organizations

    7 Marketing Co - ops: The Joint is the Official Chiropractor for Professional and Collegiate Athletic Organizations As of 9/30/2022 © 2022 The Joint Corp. All Rights Reserved.

  8. Slide 8: Q3 2022 Financial Results

    Q3 2022 Financial Results 8 $ in M 1 Q3 2022 Q3 2021 Differences Revenue • Corporate clinics • Franchise fees $26.6 15.8 10.8 $21.0 11.6 9.4 $5.6 4.2 1.4 27% 36% 15% Cost of revenue 2.5 2.3 0.2 8% Sales and marketing 3.5 2.9 0.6 23% Depreciation and amortization 2.0 1.7 0.3 21% G&A 18.1 12.8 5.3 41%

  9. Slide 9: YTD 2022 Financial Results

    YTD 2022 Financial Results as of Sept. 30, 2022 9 $ in M 1 First 9 Mos. 2022 First 9 Mos. 2021 Differences Revenue • Corporate clinics • Franchise fees $74.1 42.9 31.2 $58.8 32.5 26.2 $15.3 10.4 4.9 26% 32% 19% Cost of revenue 7.2 6.1 1.1 18% Sales and marketing 10.7 8.5 2.2 25% Depreciation and amo

  10. Slide 10: Tightening 2022 Financial Guidance

    Tightening 2022 Financial Guidance 10 $ in M 2021 Actual 2022 Low Guidance 2022 High Guidance Revenues $80.9 $100.0 $102.0 Adjusted EBITDA 1 $12.6 $11.5 $12.5 New Franchised Clinic Openings 110 110 130 New Company - owned/Managed Clinics 2 32 30 40 © 2022 The Joint Corp. All Rights Reserved. 1 Recon

  11. Slide 11: Driving Long-term Stakeholder Value

    Driving Long - term Stakeholder Value People will continue to seek more noninvasive, holistic ways to manage their pain. We’ll be there to treat them. System - wide Sales ($ in M) 67% CAGR 1 (2010 - 2021) The Joint Corp. 11 - yr. CAGR 67% 1 vs. Industry CAGR 5.4% 2* 1 For the period ended Dec. 31, 2

  12. Slide 12: Performance Metrics and Non-GAAP Measures

    Performance Metrics and Non - GAAP Measures 12 This presentation includes commonly discussed performance metrics. System - wide sales include sales at all clinics, whether operated by the company or by franchisees. While franchised sales are not recorded as revenues by the company, management believ

  13. Slide 13: Q3 2022 Segment Results

    Q3 2022 Segment Results as of Sept. 30, 2022 13 2022 Q3 © 2022 The Joint Corp. All Rights Reserved. $ in 000s

  14. Slide 14: YTD 2022 Segment Results

    YTD 2022 Segment Results as of Sept. 30, 2022 14 2022 © 2022 The Joint Corp. All Rights Reserved. $ in 000s © 2022 The Joint Corp. All Rights Reserved.

  15. Slide 15: GAAP – Non-GAAP Reconciliation

    GAAP – Non - GAAP Reconciliation 15 © 2022 The Joint Corp. All Rights Reserved. $ in 000s

  16. Slide 16: Contact Information

    Jake Singleton, CFO jake.singleton@thejoint.com The Joint Corp. | 16767 N. Perimeter Dr., Suite 110, Scottsdale, AZ 85260 | (480) 245 - 5960 https://www.facebook.com/thejointchiro @ thejointchiro https://twitter.com/thejointchiro @ thejointchiro https://www.youtube.com/thejointcorp @ thejointcorp Pe

JOINT — Q3 2022 Earnings Presentation on 6ix